Evommune, Inc.
EVMN · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $13.0M | $7.00M | +85.7% |
| Operating income | −$81.1M | −$70.0M | −15.8% |
| Net income | −$68.9M | −$66.8M | −3.1% |
Questions
- What was Evommune's revenue in FY2025?
- $13.0M in FY2025 (Fiscal year ended Dec 31, 2025), +85.7% vs $7.00M a year earlier, per its 10-K filed Mar 2026.
- Was Evommune profitable in FY2025?
- No: net income was −$68.9M and operating income −$81.1M in FY2025.